Apigenin
Internal ID | 98d03858-bcbb-4e2b-acb5-02840c9009ca |
Taxonomy | Phenylpropanoids and polyketides > Flavonoids > Flavones |
IUPAC Name | 5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one |
SMILES (Canonical) | C1=CC(=CC=C1C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O |
SMILES (Isomeric) | C1=CC(=CC=C1C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O |
InChI | InChI=1S/C15H10O5/c16-9-3-1-8(2-4-9)13-7-12(19)15-11(18)5-10(17)6-14(15)20-13/h1-7,16-18H |
InChI Key | KZNIFHPLKGYRTM-UHFFFAOYSA-N |
Popularity | 11,578 references in papers |
Molecular Formula | C15H10O5 |
Molecular Weight | 270.24 g/mol |
Exact Mass | 270.05282342 g/mol |
Topological Polar Surface Area (TPSA) | 87.00 Ų |
XlogP | 1.70 |
Atomic LogP (AlogP) | 2.58 |
H-Bond Acceptor | 5 |
H-Bond Donor | 3 |
Rotatable Bonds | 1 |
520-36-5 |
5,7-Dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one |
Versulin |
Apigenol |
4',5,7-Trihydroxyflavone |
Chamomile |
Spigenin |
Apigenine |
C.I. Natural Yellow 1 |
Pelargidenon 1449 |
There are more than 10 synonyms. If you wish to see them all click here. |

Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | + | 0.9671 | 96.71% |
Caco-2 | + | 0.9313 | 93.13% |
Blood Brain Barrier | - | 0.7750 | 77.50% |
Human oral bioavailability | - | 0.6714 | 67.14% |
Subcellular localzation | Mitochondria | 0.6655 | 66.55% |
OATP2B1 inhibitior | - | 0.6489 | 64.89% |
OATP1B1 inhibitior | + | 0.9360 | 93.60% |
OATP1B3 inhibitior | + | 0.9480 | 94.80% |
MATE1 inhibitior | + | 0.6600 | 66.00% |
OCT2 inhibitior | - | 1.0000 | 100.00% |
BSEP inhibitior | - | 0.6857 | 68.57% |
P-glycoprotein inhibitior | - | 0.8292 | 82.92% |
P-glycoprotein substrate | - | 0.9362 | 93.62% |
CYP3A4 substrate | - | 0.5417 | 54.17% |
CYP2C9 substrate | - | 0.6443 | 64.43% |
CYP2D6 substrate | - | 0.8503 | 85.03% |
CYP3A4 inhibition | + | 0.9580 | 95.80% |
CYP2C9 inhibition | + | 0.7746 | 77.46% |
CYP2C19 inhibition | + | 0.7043 | 70.43% |
CYP2D6 inhibition | - | 0.9231 | 92.31% |
CYP1A2 inhibition | + | 0.9222 | 92.22% |
CYP2C8 inhibition | + | 0.7799 | 77.99% |
CYP inhibitory promiscuity | + | 0.7316 | 73.16% |
UGT catelyzed | + | 0.8000 | 80.00% |
Carcinogenicity (binary) | - | 0.9500 | 95.00% |
Carcinogenicity (trinary) | Non-required | 0.6044 | 60.44% |
Eye corrosion | - | 0.9858 | 98.58% |
Eye irritation | + | 0.9629 | 96.29% |
Skin irritation | + | 0.5532 | 55.32% |
Skin corrosion | - | 0.9784 | 97.84% |
Ames mutagenesis | - | 0.5300 | 53.00% |
Human Ether-a-go-go-Related Gene inhibition | - | 0.8978 | 89.78% |
Micronuclear | + | 0.8200 | 82.00% |
Hepatotoxicity | + | 0.5750 | 57.50% |
skin sensitisation | - | 0.9060 | 90.60% |
Respiratory toxicity | - | 0.5111 | 51.11% |
Reproductive toxicity | + | 0.6556 | 65.56% |
Mitochondrial toxicity | - | 0.5250 | 52.50% |
Nephrotoxicity | - | 0.6638 | 66.38% |
Acute Oral Toxicity (c) | III | 0.7012 | 70.12% |
Estrogen receptor binding | + | 0.9295 | 92.95% |
Androgen receptor binding | + | 0.9419 | 94.19% |
Thyroid receptor binding | + | 0.6360 | 63.60% |
Glucocorticoid receptor binding | + | 0.9518 | 95.18% |
Aromatase binding | + | 0.9277 | 92.77% |
PPAR gamma | + | 0.9395 | 93.95% |
Honey bee toxicity | - | 0.8485 | 84.85% |
Biodegradation | - | 0.9500 | 95.00% |
Crustacea aquatic toxicity | - | 0.5900 | 59.00% |
Fish aquatic toxicity | + | 0.8272 | 82.72% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
CHEMBL1293255 | P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD+] |
28183.8 nM 22387.2 nM 31622.8 nM |
Potency Potency Potency |
via CMAUP
via CMAUP via CMAUP |
CHEMBL220 | P22303 | Acetylcholinesterase |
12 nM |
IC50 |
DOI: 10.1007/s00044-012-0353-y
|
CHEMBL3577 | P00352 | Aldehyde dehydrogenase 1A1 |
12589.3 nM 12589.3 nM 6309.6 nM 10000 nM |
Potency Potency Potency Potency |
via CMAUP
via CMAUP via CMAUP via CMAUP |
CHEMBL5983 | O60218 | Aldo-keto reductase family 1 member B10 |
37100 nM 6600 nM |
IC50 IC50 |
PMID: 26529431
PMID: 26529431 |
CHEMBL1900 | P15121 | Aldose reductase |
11900 nM |
IC50 |
PMID: 26529431
|
CHEMBL1871 | P10275 | Androgen Receptor |
5200 nM |
IC50 |
PMID: 19592245
|
CHEMBL2903 | P16050 | Arachidonate 15-lipoxygenase |
5011.9 nM |
Potency |
via CMAUP
|
CHEMBL5393 | Q9UNQ0 | ATP-binding cassette sub-family G member 2 |
3100 nM 5900 nM |
IC50 IC50 |
PMID: 21354800
PMID: 21354800 |
CHEMBL4822 | P56817 | Beta-secretase 1 |
38500 nM 38500 nM |
IC50 IC50 |
PMID: 22243648
DOI: 10.1007/s00044-012-0353-y |
CHEMBL1914 | P06276 | Butyrylcholinesterase |
37400 nM |
Ki |
PMID: 19879672
|
CHEMBL3629 | P68400 | Casein kinase II alpha |
800 nM 740 nM |
IC50 Ki |
PMID: 19414254
via Super-PRED |
CHEMBL4096 | P04637 | Cellular tumor antigen p53 |
3981.1 nM 5011.9 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL2508 | Q00534 | Cyclin-dependent kinase 6 |
1700 nM 1700 nM |
IC50 IC50 |
PMID: 15689157
DOI: 10.1007/s00044-009-9233-5 |
CHEMBL230 | P35354 | Cyclooxygenase-2 |
8000 nM |
IC50 |
PMID: 16038536
|
CHEMBL4051 | P13569 | Cystic fibrosis transmembrane conductance regulator |
9000 nM |
EC50 |
PMID: 25019478
|
CHEMBL1978 | P11511 | Cytochrome P450 19A1 |
1000 nM 900 nM 1200 nM 900 nM |
IC50 IC50 IC50 IC50 |
PMID: 18778944
PMID: 20413308 PMID: 26301554 via Super-PRED |
CHEMBL2231 | P04798 | Cytochrome P450 1A1 |
427 nM |
IC50 |
PMID: 20696580
|
CHEMBL3356 | P05177 | Cytochrome P450 1A2 |
795 nM |
IC50 |
PMID: 20696580
|
CHEMBL4878 | Q16678 | Cytochrome P450 1B1 |
25 nM 25 nM |
IC50 IC50 |
PMID: 20696580
via Super-PRED |
CHEMBL3622 | P33261 | Cytochrome P450 2C19 |
19952.6 nM 7943.3 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL3397 | P11712 | Cytochrome P450 2C9 |
5011.9 nM 31622.8 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL289 | P10635 | Cytochrome P450 2D6 |
39810.7 nM 12589.3 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL340 | P08684 | Cytochrome P450 3A4 |
7943.3 nM 1258.9 nM 3162.3 nM 7943.3 nM 1258.9 nM 3162.3 nM |
Potency Potency Potency Potency Potency Potency |
via CMAUP
via CMAUP via CMAUP via CMAUP via CMAUP via CMAUP |
CHEMBL2558 | P53355 | Death-associated protein kinase 1 |
31000 nM |
IC50 |
PMID: 26322379
|
CHEMBL284 | P27487 | Dipeptidyl peptidase IV |
140 nM |
IC50 |
via Super-PRED
|
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase |
39810.7 nM |
Potency |
via CMAUP
|
CHEMBL4159 | Q99714 | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein |
31622.8 nM 31622.8 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL3181 | P14061 | Estradiol 17-beta-dehydrogenase 1 |
710 nM 710 nM |
IC50 IC50 |
PMID: 18533708
via Super-PRED |
CHEMBL206 | P03372 | Estrogen receptor alpha |
1253 nM |
IC50 |
PMID: 12824043
|
CHEMBL242 | Q92731 | Estrogen receptor beta |
130 nM |
IC50 |
PMID: 12824043
|
CHEMBL1293278 | O75496 | Geminin |
12589.3 nM |
Potency |
via CMAUP
|
CHEMBL262 | P49841 | Glycogen synthase kinase-3 beta |
1900 nM |
IC50 |
DOI: 10.1007/s00044-012-0353-y
|
CHEMBL4331 | P68871 | Hemoglobin beta chain |
31622.8 nM |
Potency |
via CMAUP
|
CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha |
1995.3 nM 12589.3 nM 12589.3 nM 1995.3 nM |
Potency Potency Potency Potency |
via CMAUP
via CMAUP via CMAUP via CMAUP |
CHEMBL1293226 | B2RXH2 | Lysine-specific demethylase 4D-like |
11220.2 nM |
Potency |
via CMAUP
|
CHEMBL4040 | P28482 | MAP kinase ERK2 |
19952.6 nM |
Potency |
via CMAUP
|
CHEMBL1293224 | P10636 | Microtubule-associated protein tau |
19952.6 nM 8912.5 nM 10000 nM 3162.3 nM 10000 nM 15848.9 nM 8912.5 nM |
Potency Potency Potency Potency Potency Potency Potency |
via CMAUP
via CMAUP via CMAUP via CMAUP via CMAUP via CMAUP via CMAUP |
CHEMBL1951 | P21397 | Monoamine oxidase A |
1700 nM 640 nM |
IC50 IC50 |
PMID: 20045650
via Super-PRED |
CHEMBL2039 | P27338 | Monoamine oxidase B |
12800 nM |
IC50 |
PMID: 20045650
|
CHEMBL3004 | P33527 | Multidrug resistance-associated protein 1 |
4900 nM 2400 nM |
Ki Ki |
PMID: 11306701
PMID: 19725578 |
CHEMBL1250375 | Q9NPH5 | NADPH oxidase 4 |
1130 nM |
IC50 |
PMID: 20731357
|
CHEMBL5162 | Q6W5P4 | Neuropeptide S receptor |
25118.9 nM |
Potency |
via CMAUP
|
CHEMBL1293277 | O15118 | Niemann-Pick C1 protein |
5804.8 nM |
Potency |
via CMAUP
|
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit |
19952.6 nM 19952.6 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL1293235 | P02545 | Prelamin-A/C |
12589.3 nM 12589.3 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL1075189 | P14618 | Pyruvate kinase isozymes M1/M2 |
3162.3 nM 3162.3 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL1293232 | Q16637 | Survival motor neuron protein |
22387.2 nM 35481.3 nM 14125.4 nM 14125.4 nM 25118.9 nM |
Potency Potency Potency Potency Potency |
via CMAUP
via CMAUP via CMAUP via CMAUP via CMAUP |
CHEMBL6164 | O95271 | Tankyrase-1 |
3162.28 nM 3100 nM |
IC50 IC50 |
PMID: 23574272
PMID: 23574272 |
CHEMBL6154 | Q9H2K2 | Tankyrase-2 |
2951.21 nM 2900 nM |
IC50 IC50 |
PMID: 23574272
PMID: 23574272 |
CHEMBL1293256 | P40225 | Thrombopoietin |
501.2 nM 501.2 nM 501.2 nM |
Potency Potency Potency |
via CMAUP
via CMAUP via Super-PRED |
CHEMBL1947 | P10828 | Thyroid hormone receptor beta-1 |
50118.7 nM 39810.7 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL1963 | P16473 | Thyroid stimulating hormone receptor |
3981.1 nM |
Potency |
via CMAUP
|
CHEMBL3194 | P02766 | Transthyretin |
18000 nM 653 nM 250 nM |
IC50 IC50 Kd |
PMID: 26214366
via CMAUP via Super-PRED |
CHEMBL1974 | P36888 | Tyrosine-protein kinase receptor FLT3 |
1450 nM |
IC50 |
PMID: 23411073
|
CHEMBL2599 | P43405 | Tyrosine-protein kinase SYK |
4200 nM |
IC50 |
PMID: 22257213
|
CHEMBL1075138 | Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 |
8912.5 nM 1778.3 nM 7079.5 nM |
Potency Potency Potency |
via CMAUP
via CMAUP via CMAUP |
CHEMBL1293227 | O75604 | Ubiquitin carboxyl-terminal hydrolase 2 |
10000 nM |
Potency |
via CMAUP
|
CHEMBL1929 | P47989 | Xanthine dehydrogenase |
700 nM 3200 nM 520 nM |
IC50 IC50 Ki |
PMID: 9461655
PMID: 26022844 via Super-PRED |
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 97.85% | 91.11% |
CHEMBL242 | Q92731 | Estrogen receptor beta | 94.77% | 98.35% |
CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 94.20% | 89.00% |
CHEMBL2581 | P07339 | Cathepsin D | 92.99% | 98.95% |
CHEMBL2635 | P51452 | Dual specificity protein phosphatase 3 | 91.37% | 94.00% |
CHEMBL1860 | P10827 | Thyroid hormone receptor alpha | 90.26% | 99.15% |
CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 87.24% | 95.56% |
CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 85.89% | 90.71% |
CHEMBL3401 | O75469 | Pregnane X receptor | 84.73% | 94.73% |
CHEMBL3038469 | P24941 | CDK2/Cyclin A | 83.68% | 91.38% |
CHEMBL2208 | P49137 | MAP kinase-activated protein kinase 2 | 83.55% | 95.20% |
CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 83.09% | 94.45% |
CHEMBL5284 | Q96RR4 | CaM-kinase kinase beta | 82.88% | 89.23% |
CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 82.85% | 86.33% |
CHEMBL3192 | Q9BY41 | Histone deacetylase 8 | 81.29% | 93.99% |
CHEMBL1293255 | P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD+] | 80.96% | 83.57% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.